- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/385 - Haptens or antigens, bound to carriers
Patent holdings for IPC class A61K 39/385
Total number of patents in this class: 2069
10-year publication summary
146
|
151
|
152
|
150
|
124
|
162
|
142
|
132
|
117
|
57
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Glaxosmithkline Biologicals S.A. | 1636 |
109 |
Pfizer Inc. | 3367 |
40 |
The Regents of the University of California | 19812 |
34 |
Wyeth LLC | 652 |
29 |
Selecta Biosciences, Inc. | 188 |
24 |
Merck Sharp & Dohme LLC | 3741 |
23 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
20 |
The University of British Columbia | 1492 |
19 |
Northwestern University | 3364 |
18 |
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts | 354 |
18 |
SK Bioscience Co., Ltd. | 113 |
16 |
President and Fellows of Harvard College | 5949 |
14 |
Children's Medical Center Corporation | 1850 |
14 |
Ecole Polytechnique Federale de Lausanne (epfl) | 1526 |
13 |
UTi Limited Partnership | 449 |
13 |
The Trustees of the University of Pennsylvania | 4308 |
12 |
AC Immune S.A. | 257 |
12 |
The Scripps Research Institute | 1346 |
11 |
Cue Biopharma, Inc. | 186 |
11 |
The Regents of the University of Michigan | 4670 |
10 |
Other owners | 1609 |